Immunisation Community of Practice

Share Immunisation Community of Practice on Facebook Share Immunisation Community of Practice on Twitter Share Immunisation Community of Practice on Linkedin Email Immunisation Community of Practice link

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.
  • Update to AIR vaccination provider form

    Share Update to AIR vaccination provider form on Facebook Share Update to AIR vaccination provider form on Twitter Share Update to AIR vaccination provider form on Linkedin Email Update to AIR vaccination provider form link

    Two new provider types, Residential Care Facilities (RCFs) and Authorised Nurses Immunisers (ANIs) have been added to the Australian Immunisation Register (AIR) and can apply for an AIR Provider Number. This AIR update provides information and advice on possible scenarios.

    The advice is that a nurse in general practice is not required to get an AIR provider number and therefore an ABN is not needed.

    If someone is working as a contractor and needs an ABN they can apply directly to the ABR and there is no fee to get an ABN.

    Q In what settings should an ANI apply for an AIR provider number?

    A In NSW a Registered Nurse/Midwife who holds the relevant qualifications for administering immunisations independently, has an ABN and who:

    • plans on administering vaccines independently, or
    • administers vaccines at a location that does not already have or is unable to register for an AIR provider number





  • Amended Authority for Nurse/Midwife Immunisers and learning resource

    Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Facebook Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Twitter Share Amended Authority for Nurse/Midwife Immunisers and learning resource on Linkedin Email Amended Authority for Nurse/Midwife Immunisers and learning resource link

    The Authority for Nurse/Midwife Immunisers has been amended to include the following additional vaccines:

    • Japanese encephalitis vaccines – mandatory training required
    • Typhoid vaccines
    • Herpes Zoster – Shingrix only. Does not include Zostavax

    The Authority is available from: https://www.health.nsw.gov.au/immunisation/Documents/authority-for-RNs-and-midwives.pdf

    In order to administer the Japanese encephalitis vaccines Authorised Nurse/Midwife Immunisers must have completed Japanese encephalitis: A resource for registered nurses and midwives

  • Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed

    Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Facebook Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Twitter Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on Linkedin Email Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed link

    Researchers at the National Centre for Immunisation Research and Surveillance (NCIRS) are conducting a study investigating the current utilisation of vaccine safety surveillance systems by immunisation providers across Australia. To help inform this study, you are invited to participate in a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice.

    The findings from this study will help improve vaccine safety surveillance systems in Australia, ensuring they are fit-for-purpose for the needs of you and your patients in the future.

    Click here to register your interest

    Participants will be given a voucher for their time and interviews can be scheduled at a time that suits you to ensure there is no impact on your ability to see patients. Interviews will take place throughout October and November.

    For further information or if you have any questions about the study, please email NCIRS Senior Program Officer, Nicola Carter at Nicola.Carter@health.nsw.gov.au

    Expressions of interest close 30 October 2022.

  • Flu reimbursement - vendor invite not received??

    Share Flu reimbursement - vendor invite not received?? on Facebook Share Flu reimbursement - vendor invite not received?? on Twitter Share Flu reimbursement - vendor invite not received?? on Linkedin Email Flu reimbursement - vendor invite not received?? link

    If your practice has not received the vendor email invite to obtain your reimbursement for private flu vaccines. Please email kwisemantel@thephn.com.au with your details and best email address and I can action it with the Ministry of Health.

  • ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022)

    Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Facebook Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Twitter Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on Linkedin Email ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) link

    The Australian Technical Advisory Group on Immunisation (ATAGI) has developed guidelines to provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. The guidelines are available on the Department of Health and Aged Care website.

    The latest version (7 September 2022) includes updated advice on incorrect storage and handling and consolidated advice on unapproved age group.

  • Vaccination provider information payments

    Share Vaccination provider information payments on Facebook Share Vaccination provider information payments on Twitter Share Vaccination provider information payments on Linkedin Email Vaccination provider information payments link

    Immunisation payment statement

    Recognised vaccination providers can access their monthly immunisation payment statement on the AIR site.

    The benefits of accessing your payment statements from the AIR site are:

    • they’re available immediately after each payment run
    • you can view, save or print them as often as you need to
    • you can access them when it’s convenient for you
    • using your PRODA account, you can use any internet connected device including your PC, mobile phone or tablet.

    The immunisation notifications reconciliation report includes immunisation details recorded on the AIR during the last month. It lists details about immunisation claims, AIR payments and reasons why a claim may not be payable.

    This report is available on the AIR site on the second last Tuesday of each month.

    Service Australia Vaccination Provider Information Payments


  • How to claim Flu Vaccine Reimbursement

    Share How to claim Flu Vaccine Reimbursement on Facebook Share How to claim Flu Vaccine Reimbursement on Twitter Share How to claim Flu Vaccine Reimbursement on Linkedin Email How to claim Flu Vaccine Reimbursement link

    How to claim:

    1. Complete the reimbursement form (one form per practice)
    2. Attach vaccine purchase invoice
    3. Email to: MOH-NSWHealth@health.nsw.gov.au (no confirmation email is sent)

    Deadline: COB Friday 26th August 2022

    Next steps:

    Approximately 1-2 weeks after your email has been sent, you will receive an additional email from NSW Health

    • From email HSNSW-eBusiness.WorkflowMailer@health.nsw.gov.au
    • Subject line:For Your Information: Invitation to register from Health System Support Group”
    • With a request to set up your practice as a vendor in the NSW Health system
    • Once you have been set up as a vendor, your payment request will be processed

    If you have any questions regarding this reimbursement process, please contact NSW Health MOH-NSWHealth@health.nsw.gov.au.

  • Pneumococcal pneumonia: Awareness campaign

    Share Pneumococcal pneumonia: Awareness campaign on Facebook Share Pneumococcal pneumonia: Awareness campaign on Twitter Share Pneumococcal pneumonia: Awareness campaign on Linkedin Email Pneumococcal pneumonia: Awareness campaign link
    supporting image

    Pfizer is sponsoring a 6-week consumer awareness radio campaign on pneumococcal pneumonia that will commence on 29th August 2022 on 2GB in Sydney and 3AW in Melbourne. This campaign is a pilot and may be extended to other cities later this year.

    There are 15 second and 30 second versions of two different ads, directing consumers to visit mylunghealth.com.au to take a short quiz to assess their risk of pneumococcal pneumonia and to speak to their doctor or nurse for more information.

    You can listen to the 30 second versions of the ads by clicking the links below.

    Since July 2020, one dose of Prevenar 13® is funded for non-Indigenous adults 70 years and older, Indigenous adults 50 years and older* and people with certain risk conditions*. Prevenar 13® can be given at any time of year and only one dose is needed.

    Prevenar 13® is recommended even in patients who have previously received 23vPPV, at least 12 months after their 23vPPV dose.

    Please visit the Australian Immunisation Handbook for a complete list of funded risk conditions and pneumococcal vaccine recommendations https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease#recommendations

    *followed by 23vPPV doses

  • Virtual Coast to Country Immunisation Conference 2022: Share Your Story

    Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Facebook Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Twitter Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Linkedin Email Virtual Coast to Country Immunisation Conference 2022: Share Your Story link

    Share Your Immunisation Story via a photo or video

    Are you interested in sharing your story via a pre-flimed video on how you have overcome or addressed an immunisation problem or have a great story to share?

    If so please email details of your story to Rebecca at rbrennan@thephn.com.au, by Friday September 2nd

  • Today is National Aboriginal and Torres Strait Islander Children’s Day

    Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Facebook Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Twitter Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Linkedin Email Today is National Aboriginal and Torres Strait Islander Children’s Day link
    supporting image

    On this day I'd like to remind you that the meningococcal B vaccine (Bexsero®) was added to the National Immunisation Program schedule for Aboriginal and Torres Strait Islander children <2 years of age, on the 1 July 2020.

    Why is it being funded?

    The incidence of invasive meningococcal disease (IMD) caused by serogroup B is highest in young children compared with other age groups and it is about 4 times higher in Aboriginal and Torres Strait Islander children aged <2 years than in non-Indigenous children.

    Immunisation providers are reminded to identify Aboriginal and Torres Strait Islander people within your practices and discuss the need for additional recommended vaccines. It is important to alert parents of the need to buy paracetamol prior to vaccination.

    Dose schedule

    The number of Bexsero® doses required depends on age and presence of any medical conditions that increase the risk of IMD. For Aboriginal and Torres Strait Islander children with:

    • no medical risk conditions: 3 doses in total (given at 2*, 4 and 12 months of age)
    • with risk conditions for IMD:4 doses in total (given at 2*, 4, 6 and 12 months of age)

    Catch-up vaccination

    Meningococcal B vaccine catch-up is available for all Aboriginal and Torres Strait Islander children aged <2 years until 30 June 2023.

    Co-administration with other vaccines

    The meningococcal B vaccine (Bexsero®) can be safely administered with other childhood vaccines and can be given at the same time at the 2*, 4 and 12 months schedule points.

    Meningococcal vaccines for Australians - NCIRS fact sheet

    Clinical advice for vaccination providers - Meningococcal vaccination schedule from 1 July 2020

    Meningococcal B consumer resources

    • Order posters here
    • Order brochures here

    Hear from this year's Aboriginal and Torres Strait Islander Children's Day Ambassador Thomas Mayor about the 2022 theme and how to get involved: https://buff.ly/3oSOLLQ

Page last updated: 05 Sep 2024, 02:55 PM